R&D

News

InnoCare and Eli Lilly logos over a handshake graphic in the background

Lilly forges $3.35bn alliance with China's InnoCare

Eli Lilly continues a busy period of deal-making with a five-project partnership with InnoCare that includes $100m in upfront and near-term payments.

News

Under pressure, Novo lays out blockbuster launch plans

Novo has revealed a plan to launch five or more blockbusters between now and 2030 that it hopes will grow annual revenues by around $23bn.

News

TikTok parent ByteDance raises cash for drug AI spinout Anew

Chinese tech giant ByteDance, best known as the parent of TikTok, has completed a $290m financing for its AI drug discovery spinout Anew Labs.

News

FDA unveils framework for its expedited IND pilot

The FDA has published the design of its expedited Investigational New Drug pilot, part of a plan to restore US competitiveness in clinical research.

News

Andy Plump to step down as Takeda's R&D chief

Andy Plump, credited with a 'soup-to-nuts' overhaul of Takeda's R&D in more than a decade of leadership at the division, has announced his retirement.

News

Could UK clinical trial revamp unlock closer ties with Canad...

Two senior figures in Canada's life science sector have said they see scope for greater collaboration with the UK following clinical trial reforms.

Lilly forges $3.35bn alliance with China's InnoCare

Under pressure, Novo lays out blockbuster launch plans

TikTok parent ByteDance raises cash for drug AI spinout Anew

FDA unveils framework for its expedited IND pilot

Andy Plump to step down as Takeda's R&D chief

Could UK clinical trial revamp unlock closer ties with Canad...

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks